Endurance Wealth Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $0 | Hold |
400
| – | – | ﹤0.01% | 647 |
|
|
2023
Q1 | $1K | Hold |
400
| – | – | ﹤0.01% | 624 |
|
|
2022
Q4 | $1K | Hold |
400
| – | – | ﹤0.01% | 612 |
|
|
2022
Q3 | $2K | Hold |
400
| – | – | ﹤0.01% | 563 |
|
|
2022
Q2 | $1K | Hold |
400
| – | – | ﹤0.01% | 604 |
|
|
2022
Q1 | $2K | Hold |
400
| – | – | ﹤0.01% | 608 |
|
|
2021
Q4 | $4K | Hold |
400
| – | – | ﹤0.01% | 552 |
|
|
2021
Q3 | $4K | Hold |
400
| – | – | ﹤0.01% | 561 |
|
|
2021
Q2 | $6K | Hold |
400
| – | – | ﹤0.01% | 555 |
|
|
2021
Q1 | $6K | Hold |
400
| – | – | ﹤0.01% | 565 |
|
|
2020
Q4 | $8K | Hold |
400
| – | – | ﹤0.01% | 510 |
|
|
2020
Q3 | $6K | Hold |
400
| – | – | ﹤0.01% | 521 |
|
|
2020
Q2 | $6K | Hold |
400
| – | – | ﹤0.01% | 503 |
|
|
2020
Q1 | $5K | Buy |
+400
| New | +$5K | ﹤0.01% | 467 |
|